Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.
Gonçalves A, Gilabert M, François E, Dahan L, Perrier H, Lamy R, Re D, Largillier R, Gasmi M, Tchiknavorian X, Esterni B, Genre D, Moureau-Zabotto L, Giovannini M, Seitz JF, Delpero JR, Turrini O, Viens P, Raoul JL. Gonçalves A, et al. Among authors: esterni b. Ann Oncol. 2012 Nov;23(11):2799-2805. doi: 10.1093/annonc/mds135. Epub 2012 Jul 5. Ann Oncol. 2012. PMID: 22771827 Free article. Clinical Trial.
A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.
Gonçalves A, Esteyries S, Taylor-Smedra B, Lagarde A, Ayadi M, Monges G, Bertucci F, Esterni B, Delpero JR, Turrini O, Lelong B, Viens P, Borg JP, Birnbaum D, Olschwang S, Viret F. Gonçalves A, et al. Among authors: esterni b. BMC Cancer. 2008 Jun 10;8:169. doi: 10.1186/1471-2407-8-169. BMC Cancer. 2008. PMID: 18544172 Free PMC article.
Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
Moureau-Zabotto L, Farnault B, de Chaisemartin C, Esterni B, Lelong B, Viret F, Giovannini M, Monges G, Delpero JR, Bories E, Turrini O, Viens P, Salem N. Moureau-Zabotto L, et al. Among authors: esterni b. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):483-91. doi: 10.1016/j.ijrobp.2010.02.025. Epub 2010 Nov 18. Int J Radiat Oncol Biol Phys. 2011. PMID: 21093174
Assessment of prognostic scores in brain metastases from breast cancer.
Tabouret E, Metellus P, Gonçalves A, Esterni B, Charaffe-Jauffret E, Viens P, Tallet A. Tabouret E, et al. Among authors: esterni b. Neuro Oncol. 2014 Mar;16(3):421-8. doi: 10.1093/neuonc/not200. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24311640 Free PMC article.
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.
Gonçalves A, Esterni B, Bertucci F, Sauvan R, Chabannon C, Cubizolles M, Bardou VJ, Houvenaegel G, Jacquemier J, Granjeaud S, Meng XY, Fung ET, Birnbaum D, Maraninchi D, Viens P, Borg JP. Gonçalves A, et al. Among authors: esterni b. Oncogene. 2006 Feb 16;25(7):981-9. doi: 10.1038/sj.onc.1209131. Oncogene. 2006. PMID: 16186794
73 results